<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Among 39 posttransplant <z:e sem="disease" ids="C0024314" disease_type="Neoplastic Process" abbrv="">lymphoproliferative diseases</z:e> (PTLD) in a cohort of 450 pediatric liver transplant recipients, 3 had a malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, unresponsive to arrest of immunosuppression and to <z:chebi fb="1" ids="465284">gancyclovir</z:chebi>, interferon, and anti-interleukin 6 antibodies </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0002665'>Lymphoma</z:hpo> appeared 20, 46, and 96 months posttransplantation and 16, 43, and 90 months after primary <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">Epstein-Barr virus infection</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>In one case, the patient had histological progression from plasmacytic <z:mpath ids='MPATH_134'>hyperplasia</z:mpath> PTLD, concomitant with symptomatic <z:e sem="disease" ids="C0948192" disease_type="Disease or Syndrome" abbrv="">primary infection</z:e>, to Burkitt-like <z:hpo ids='HP_0002665'>lymphoma</z:hpo> 43 months later </plain></SENT>
<SENT sid="3" pm="."><plain>These three patients received five courses of chemotherapy, after a <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, <z:chebi fb="0" ids="28748">doxorubicin</z:chebi>, <z:chebi fb="0" ids="28445">vincristine</z:chebi>, and <z:chebi fb="0" ids="8382">prednisone</z:chebi> regimen for Burkitt-like or LH 89 scheme for <z:e sem="disease" ids="C1334036" disease_type="Neoplastic Process" abbrv="">Hodgkin-like PTLDs</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Chemotherapy was well tolerated, and <z:hpo ids='HP_0000001'>all</z:hpo> three were free of disease and without immunosuppression 19, 14, and 4 months after chemotherapy </plain></SENT>
<SENT sid="5" pm="."><plain>In Burkitt-like or <z:e sem="disease" ids="C1334036" disease_type="Neoplastic Process" abbrv="">Hodgkin-like PTLDs</z:e>, immunomodulatory or <z:chebi fb="1" ids="36044">antiviral drugs</z:chebi> were inefficient </plain></SENT>
<SENT sid="6" pm="."><plain>Chemotherapy is indicated and can be safely and successfully used </plain></SENT>
<SENT sid="7" pm="."><plain>Long-term arrest of immunosuppression seems feasible without graft rejection </plain></SENT>
</text></document>